Dr Reddy's Laboratories Ltd
SWB:RDDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Dr Reddy's Laboratories Ltd (RDDA) under the Base Case is EUR per share.
Compared with the current market price of 13.3 EUR, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Dr Reddy's Laboratories Does
Dr Reddy's Laboratories makes and sells generic medicines, branded prescription drugs, and active pharmaceutical ingredients, or the chemical ingredients used to make medicines. It also develops some specialty products and biosimilars for complex diseases. The company serves patients, doctors, pharmacies, hospitals, and health systems in India and in overseas markets such as the United States, Europe, and other regulated regions.
- Headquarters
- India IN
- Employees
- 27 527
- IPO date
- Jan 1, 1986
Dr Reddy's Laboratories has a narrow economic moat
Hard-to-obtain drug approvals and the work needed to develop complex medicines give Dr Reddy's protection in selected products. Rivals must invest in development, testing and approved manufacturing before they can compete, although ordinary generic medicines face much stronger price competition.
Read the full moat analysis
Revenue & Expenses Breakdown
Dr Reddy's Laboratories Ltd
Earnings Waterfall
Dr Reddy's Laboratories Ltd
What is the Intrinsic Value of one RDDA stock?
The intrinsic value for Dr Reddy's Laboratories Ltd (RDDA) under the Base Case is EUR.
Is RDDA stock undervalued or overvalued?
Compared with the current market price of 13.3 EUR, the stock appears .
